How many clinical trials are studying 18F-DCFPyL?

6 recruiting trials in our tracked data involve 18F-DCFPyL.

What conditions is 18F-DCFPyL being studied for?

In our tracked recruiting trials, 18F-DCFPyL is being studied in trials for Prostate Cancer, Biochemically Recurrent, Breast Cancer.

Recruiting trials

Conditions studied

US states with sites

Countries

Early Phase 1 1 Phase 2 3 Phase 4 1 Not applicable 1

Condition	Trials
Prostate Cancer · 18F-DCFPyL for Prostate Cancer	6
Biochemically Recurrent	1
Breast Cancer	1
HER2-negative Breast Cancer	1
Localized Prostate Cancer	1
Metastatic Breast Cancer	1
Metastatic Castration-resistant Prostate Cancer	1
Metastatic Castration-resistant Prostate Carcinoma	1
Prostate Adenocarcinoma	1
Prostatic Neoplasms	1

18F-DCFPyL Imaging as a Method to Assess Treatment Response to Stereotactic Body Radiation Therapy
NCT05155046 · Phase: Phase 2 · Ages: 18 Years to 120 Years · Sex: Male · 1 location
Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer
NCT04573231 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
Focal Therapy With Stereotactic Body Radiation Therapy (SBRT) for Patients With a Single Prostate Tumor
NCT05616650 · Phase: Phase 2 · Ages: 18 Years to 120 Years · Sex: Male · 1 location
Image-guided Focal Brachytherapy Utilizing Combined 18F-DCFPyl PET/CT
NCT03861676 · Phase: Early Phase 1 · Ages: 18 Years to 100 Years · Sex: Male · 1 location
Pilot of 18F-DCFPyL-PSMA PET in mCRPC Patients Receiving 117Lu-Vipivotide Tetraxetan
NCT06099093 · Phase: Phase 4 · Ages: 18 Years and older · Sex: Male · 2 locations
Prospective Monitoring of Subjects With Biochemically Recurrent Prostate Cancer Using 18FDCFPyL
NCT05588128 · Phase: Not specified · Ages: 18 Years and older · Sex: Male · 1 location